Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
2025;24:e70205
The clinical trial safety data applies exclusively to weekly dosing
In humans, retrospective cohort studies have found people taking GLP-1RAs are less likely to develop alcohol use disorder (AUD) 16 and less likely to be hospitalized for acute alcohol intoxication 17
Researchers can use this data to optimize COA design or selection regardless of modality, target demographic, or indication, with potential positive effects on comparability, translatability, data quality, and the patient experience, as COAs and expectations about them converge on more straightforward and familiar structures and language
US$ 22.10
US$ 28.82
US$ 22.43
US$ 28.45
US$ 25.45
US$ 25.67
